LENZ Therapeutics, Inc.LENZNASDAQ

Revenue (LTM)

Net Income (LTM)

$-50M

+28.9% YoY

Free Cash Flow

$-60M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	15	0	0
Gross Profit	-0	-1↓506.6%	15↑2143.6%	0	-0
Operating Income	-14	-60↓347.7%	-10↑82.7%	-72↓590.9%	-59↑19.1%
Net Income	-68	-71↓3.5%	-11↑84.7%	-70↓547.2%	-50↑28.9%
EBITDA	-68	-70↓2.7%	-10↑85.0%	-72↓591.3%	-50↑31.4%
EPS Diluted	-8.24	-8.54↓3.6%	-12.89↓51.0%	-15.30↓18.7%	-2.34↑84.7%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	20	18↓7.6%	44↑142.8%	35↓20.9%	20↓42.6%
Total Current Assets	21	18↓13.2%	47↑154.5%	67↑44.2%	212↑215.1%
Total Assets	23	18↓18.7%	47↑156.1%	70↑49.9%	215↑205.9%
Total Current Liabilities	32	1↓96.1%	9↑658.1%	19↑94.9%	10↓43.8%
Total Liabilities	32	33↑0.6%	71↑118.5%	163↑129.3%	11↓93.1%
Total Equity	-10	-14↓45.0%	-24↓70.0%	-93↓283.6%	204↑320.1%
Total Debt	0	0	0	0↑31.6%	1↑319.8%
Net Debt	-20	-18↑7.6%	-44↓141.4%	-35↑21.2%	-19↑46.1%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-9	-53↓506.0%	-88↓66.5%	-60↑31.4%	-59↑1.6%
Capital Expenditure	-2	-6↓271.5%	-7↓14.9%	-0↑99.5%	-0↓1460.0%
Free Cash Flow	-10	-59↓470.7%	-95↓61.4%	-60↑36.1%	-60↑0.9%
Stock-Based Comp	0	0	0	1	6↑373.9%
Net Change in Cash	20	357↑1702.8%	-329↓192.2%	-9↑97.2%	-15↓59.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance